Table 3.
Visit 1 | Visit 2 | Visit 3 | Visit 4 | |||||
---|---|---|---|---|---|---|---|---|
Statistic | P‐value | Statistic | P‐value | Statistic | P‐value | Statistic | P‐value | |
T 2 | F(1, 36) = 47.805 | 4.05E‐08 | F(1, 36) = 46.726 | 5.15E‐08 | F(1, 36) = 49.616 | 2.73E‐08 | F(1, 37) = 49.826 | 2.34E‐08 |
DIXON FF | F(1, 35) = 58.047 | 6.01E‐09 | F(1, 35) = 57.432 | 6.76E‐09 | F(1, 35) = 59.244 | 4.78E‐09 | F(1, 35) = 60.985 | 3.40E‐09 |
MP‐FF | F(1, 36) = 57.048 | 6.47E‐09 | F(1, 36) = 58.461 | 5.08E‐09 | F(1, 36) = 62.389 | 2.45E‐09 | F(1, 36) = 64.510 | 1.56E‐09 |
CSA | F(1, 36) = 55.220 | 9.16E‐09 | F(1, 36) = 58.609 | 4.71E‐09 | F(1, 36) = 55.300 | 9.02E‐09 | F(1, 36) = 60.278 | 3.13E‐09 |
All alpha levels for a visit are corrected using Bonferroni adjustment. CSA, muscle cross‐sectional area; FF, fat fraction; HV, healthy volunteers; SMA, spinal muscular atrophy.